| Mr Robert Paul Babineaux, PHARMACIST | |
|
1213 E Trinity Mills Rd, Carrollton, TX 75006-1446 | |
| (972) 245-2323 | |
| Not Available |
| Full Name | Mr Robert Paul Babineaux |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1213 E Trinity Mills Rd, Carrollton, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114520855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20194 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Paul Babineaux, PHARMACIST 1213 E Trinity Mills Rd, Carrollton, TX 75006-1446 Ph: (972) 245-2323 | Mr Robert Paul Babineaux, PHARMACIST 1213 E Trinity Mills Rd, Carrollton, TX 75006-1446 Ph: (972) 245-2323 |
News Archive
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
BD, a leading global medical technology company, today reported quarterly revenues of $1.888 billion for the first fiscal quarter ended December 31, 2011, representing an increase of 2.5 percent from the prior-year period, or 2.4 percent on a foreign currency-neutral basis.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring. Colvera is the result of a decade of research, development and clinical validation in more than 4,000 patients.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
› Verified 1 days ago
Dr. Gabriel Castaneda, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006 Phone: 432-553-2286 | |
Sem Ee Kwon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1804 E Hebron Pkwy, Carrollton, TX 75010 Phone: 972-939-1977 | |
Dr. Han Ngoc Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4038 Old Denton Rd, Carrollton, TX 75007 Phone: 972-512-3366 | |
Hoa G Pham, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4038 Old Denton Rd, Carrollton, TX 75007 Phone: 763-670-1277 | |
Gina Rosson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006 Phone: 800-508-0960 | |
Aaron Broadwell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006 Phone: 800-273-3455 | |
Rekha Daniel, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006 Phone: 800-508-0960 |